levodopa has been researched along with rolipram in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Brennan, L; Gajraj, N; Howcroft, B; Parkes, JD; Ruiz, J; Thompson, C | 1 |
| Coello, C; Foltynie, T; Gunn, RN; Mehta, MA; Niccolini, F; Pagano, G; Politis, M; Rabiner, EA; Searle, GE; Wilson, H | 1 |
3 other study(ies) available for levodopa and rolipram
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Rolipram in Parkinson's disease.
Topics: Antiparkinson Agents; Drug Therapy, Combination; Ergot Alkaloids; Humans; Levodopa; Parkinson Disease; Pyrrolidinones; Rolipram | 1984 |
Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Brain Mapping; Carbon Radioisotopes; Cognition; Cyclic Nucleotide Phosphodiesterases, Type 4; Female; Humans; Levodopa; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phosphodiesterase 4 Inhibitors; Positron-Emission Tomography; Radiopharmaceuticals; Rolipram; Spatial Memory | 2017 |